Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Augustine Iannotta"'
Autor:
Richard J. Lin, Colette N. Owens, Esther Drill, Augustine Iannotta, Mayan Oliveros, Dylan L. Schick, Ariela Noy, John F. Gerecitano, Pamela R. Drullinsky, Philip C. Caron, Anita Kumar, Matthew J. Matasar, Craig Moskowitz, Beatriz Korc-Grodzicki, Andrew D. Zelenetz, Gilles A. Salles, Paul A. Hamlin
Publikováno v:
Haematologica, Vol 107, Iss 5 (2021)
Diffuse large B-cell lymphoma (DLBCL) predominantly affects older adults with suboptimal therapeutic outcomes due to increased treatment-related mortality and toxicities in vulnerable patients, clinically defined by geriatric impairments such as func
Externí odkaz:
https://doaj.org/article/addc2a88dd6f4f718d5313e1a1df2a7a
Autor:
Colette Owens, Augustine Iannotta, Paul A. Hamlin, Gilles Salles, Beatriz Korc-Grodzicki, Matthew J. Matasar, Mayan Oliveros, Ariela Noy, Dylan L Schick, Craig H. Moskowitz, Pamela Drullinsky, Philip Caron, John F. Gerecitano, Esther Drill, Andrew D. Zelenetz, Anita Kumar, Richard J. Lin
Publikováno v:
Haematologica. 107(5)
Diffuse large B-cell lymphoma (DLBCL) predominantly affects older adults with suboptimal therapeutic outcomes due to increased treatment-related mortality and toxicities in vulnerable patients, clinically defined by geriatric impairments such as func
Autor:
Augustine Iannotta, John F. Gerecitano, Maria Lia Palomba, Colette Owens, Pamela Drullinsky, David J. Straus, Matthew J. Matasar, Steven M. Horwitz, Carol S. Portlock, Paul A. Hamlin, Anita Kumar, Andrew D. Zelenetz, Ariela Noy, Craig H. Moskowitz
Publikováno v:
Journal of Clinical Oncology. 33:8571-8571
8571 Background: Older pts with DLBCL are increasing in the US and are most vulnerable to treatment related toxicities and mortality (TRM). Effective tools to predict and mitigate toxicity are esse...
Autor:
Jannelle Walkley, Carla Casulo, Pamela Drullinsky, Alison J. Moskowitz, Craig H. Moskowitz, Augustine Iannotta, Andrew D. Zelenetz, Paul A. Hamlin
Publikováno v:
Blood. 124:1751-1751
Introduction: Mantle cell lymphoma (MCL) is a heterogeneous disease and risk-stratification of patients (pts) for treatment is not performed routinely. For older pts ineligible for aggressive treatments, comprehensive geriatric assessments (CGA) are